Adjuvant FOLFOX treatment for stage III colon cancer: how many cycles are enough?

PURPOSE: Adjuvant FOLFOX (5-fluorouracil and oxaliplatin) chemotherapy benefits stage III colon cancer patients. However, it still results in side effects and increased cost. Reducing cycles had been thought to decrease these problems. This retrospective study aimed to find the appropriate number of...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Springerplus
Main Authors: Tsai, Yi-Jian, Lin, Jen-Kou, Chen, Wei-Shone, Jiang, Jeng-Kai, Teng, Hao-Wei, Yen, Chueh-Chuan, Lin, Tzu-chen, Yang, Shung-Haur
Format: Artigo
Jezik:Inglês
Izdano: Springer International Publishing 2016
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4980863/
https://ncbi.nlm.nih.gov/pubmed/27563513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40064-016-2976-9
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki